6-methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-α-reductase activity
- 1 January 1995
- journal article
- Published by Wiley in The Prostate
- Vol. 26 (1) , 28-34
- https://doi.org/10.1002/pros.2990260107
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of 6-methylene progesterone on growth, morphology, and blood flow of the dunning R3327 prostatic adenocarcinomaThe Prostate, 1992
- A new approach to prostate cancerJournal of Pharmacy and Pharmacology, 1989
- Prostate III—A structural feature characteristic of the rat prostate 5α-reductase active siteJournal of Steroid Biochemistry, 1989
- A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivityBritish Journal of Cancer, 1987
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implicationsThe Prostate, 1986
- Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosteroneJournal of Pharmacy and Pharmacology, 1984
- Prostatic cancer—II. Inhibitors of rat prostatic 4-ene-3-ketosteroid 5α-reductase derived from 6-methylene-4-androsten-3-onesJournal of Steroid Biochemistry, 1983
- Inhibitory effects of some steroidal 6-methylene derivatives on 5α-reductase activity in human and rat prostateJournal of Steroid Biochemistry, 1983
- Inhibition of prostatic growth in rats by 6-methylene-4-pregnene-3,20-dioneJournal of Endocrinology, 1982
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941